Doo-Man Oh

1.7k citations
6 papers · 1.3k indexed · 1 hit paper · h-index 4

Impact in

Papers in

Doo-Man Oh

6 papers receiving 1.3k citations

Hit Papers

Prodrugs: design and clinical applications 2008 · 1.2k citations
1.2k20082026201420204008001.2k

Peers

Doo-Man Oh
Comparison fields: 5 of 106
  • Pharmaceutical Science 165
  • Biomaterials 206
  • Pharmacology 100
  • Organic Chemistry 284
  • Molecular Biology 588
Replace Hanna Kumpulainen with:
Hanna Kumpulainen Finland
Reza Oliyai United States
Günther Wess Germany
Prashant S. Kharkar India
Yongtao Duan China
Frank Senner Switzerland
Yogendra Nayak India
Rosanna Filosa Italy
Robert A. Conradi United States
Allen R. Hilgers United States
Doo-Man Oh relative to Hanna Kumpulainen Finland Hanna Kumpulainen's profile →
Citations per field
00.5×1.5×
Hanna Kumpulainen · 1×
Citations per year

Countries citing papers authored by Doo-Man Oh

Since Specialization
Citations

This map shows the geographic impact of Doo-Man Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doo-Man Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doo-Man Oh more than expected).

Fields of papers citing papers by Doo-Man Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doo-Man Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doo-Man Oh. The network helps show where Doo-Man Oh may publish in the future.

Co-authorship network

The 16 scholars most cited alongside Doo-Man Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Doo-Man Oh Line = papers co-authored together Doo-Man Oh links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Prodrugs: design and clinical applications
Hit paper breakdown →
20081236
2 200341
3
Uptake of a Dipeptide by the Dipeptide Transporter in the HT-29 Intestinal Cells
19951
4 19951
5 199315
6
Estimating oral drug absorption in humans.
19914

About Doo-Man Oh

Doo-Man Oh is a scholar working on Biochemistry, Gastroenterology, Oncology, Pharmacology and Computational Theory and Mathematics, having authored 6 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Amino Acid Enzymes and Metabolism (2 papers), Biochemical and Molecular Research (1 paper), Gastroesophageal reflux and treatments (1 paper), Click Chemistry and Applications (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), HIV/AIDS drug development and treatment (1 paper) and Aldose Reductase and Taurine (1 paper). The work is most often cited by research in Pharmaceutical Science (165 citations), Biomaterials (206 citations), Pharmacology (100 citations), Organic Chemistry (284 citations) and Molecular Biology (588 citations). Doo-Man Oh has collaborated with scholars based in United States, Finland and South Korea. Frequent co-authors include Tycho Heimbach, Reza Oliyai, Jarkko Rautio, Jouko Savolainen, Tomi Järvinen, Hanna Kumpulainen, Hussein Hallak, Gordon L. Amidon, Narayanan Surendran and Adriaan Cleton. Their work appears in journals such as Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics, Journal of Pharmaceutical Investigation, Archives of Pharmacal Research and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026